PATENT CLAIM ANALYSIS

Application Number: 15759137
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["514", "172000"]

Abstract:
The present disclosure relates to a pharmaceutical composition comprising dutasteride and propylene glycol monolaurate, and a capsule formulation comprising the same.

Claim (Index 11):
A capsule formulation comprising the pharmaceutical composition of  claim 3 .

Metadata:
- Claim Count in Document: 44.0
- Percentile: 90.0
- Lexical Diversity: 1.15
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16065830', '14003445', '14204259', '15485813', '15153035']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7435788224708335
- 35 USC 102 Novelty (BERT): 0.4884253427227082
- Combined Prediction Score: 0.718063474496021
- Mean Citation Score: 201.610366
- Max Citation Score: 266.04657000000003
- Similarity Product: 246.4938656894821

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test